Related Articles
Diallyl trisulfide induces apoptosis in human primary colorectal cancer cells
Reversion of P-glycoprotein-mediated multidrug resistance by diallyl trisulfide in a human osteosarcoma cell line
Diallyl trisulfide reverses drug resistance and lowers the ratio of CD133+ cells in conjunction with methotrexate in a human osteosarcoma drug-resistant cell subline
Diallyl trisulfide sensitizes human melanoma cells to TRAIL-induced cell death by promoting endoplasmic reticulum-mediated apoptosis
Treatment of Saos‑2 osteosarcoma cells with diallyl trisulfide is associated with an increase in calreticulin expression